Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice ; volume:8 ; number:1 ; day:1 ; month:5 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (1.5.2018), 1-14, 12.2018
- Creator
-
Kim, Kook Hwan
- Contributor
-
Kim, Seong Hun
Han, Dai Hoon
Jo, Young Suk
Lee, Yong-ho
Lee, Myung-Shik
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-25098-0
- URN
-
urn:nbn:de:101:1-2018062922124331199830
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Kook Hwan
- Kim, Seong Hun
- Han, Dai Hoon
- Jo, Young Suk
- Lee, Yong-ho
- Lee, Myung-Shik
- SpringerLink (Online service)
Other Objects (12)
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
Challenges and opportunities in nonalcoholic steatohepatitis
P2.34 The Presence of Cirrhosis Ameliorates the Arterial Stiffness in Patients with Non-Alcoholic Steatohepatitis
Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
Challenges and opportunities in nonalcoholic steatohepatitis
P2.34 The Presence of Cirrhosis Ameliorates the Arterial Stiffness in Patients with Non-Alcoholic Steatohepatitis
Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Author Correction: Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
The Cape Gooseberry Constituent Physalin B Ameliorates Nonalcoholic Steatohepatitis and Attenuates Liver Fibrosis
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
Challenges and opportunities in nonalcoholic steatohepatitis
P2.34 The Presence of Cirrhosis Ameliorates the Arterial Stiffness in Patients with Non-Alcoholic Steatohepatitis